SEC Form 4 · accession 0001104659-17-058896
Nabriva Therapeutics plc · NBRV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Colin Broom M.D.
Officer — Chief Executive Officer · Director
Period of report
Sep 22, 2017
Accepted (ET)
Sep 26, 2017 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641640
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Sep 22, 2017 | P | 2,588 | $8.35 | A | 87,151 | D | |
| Ordinary Shares | holding | — | — | — | 72,849 | I | By grantor retained annuity trust |
Table II — derivative securities
No Table II lines on this filing.